“Ring-Fencing” BRCA1 Tumor Suppressor Activity

Slides:



Advertisements
Similar presentations
Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
Advertisements

Mechanistic Insight into Site-Restricted Monoubiquitination of FANCD2 by Ube2t, FANCL, and FANCI Arno F. Alpi, Paul E. Pace, M. Madan Babu, Ketan J. Patel.
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia Tim C.P. Somervaille, Michael L. Cleary Cancer Cell.
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung Zvi Granot, Erik Henke, Elizabeth A. Comen, Tari A. King, Larry Norton, Robert Benezra.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
A Conditional Mouse Model of Synovial Sarcoma: Insights into a Myogenic Origin Malay Haldar, Jeffrey D. Hancock, Cheryl M. Coffin, Stephen L. Lessnick,
Illuminating the Properties of Prostate Luminal Progenitors
Cutaneous Cancer Stem Cells: β-Catenin Strikes Again
Linking miRNA Regulation to BCR-ABL Expression: The Next Dimension
Focus on lymphangiogenesis in tumor metastasis
Is NF-κB2/p100 a direct activator of programmed cell death?
Sonja Schmid, Thorsten Hugel  Molecular Cell 
“Ring-Fencing” BRCA1 Tumor Suppressor Activity
Metastasis gets site specific
PI3K Regulatory Subunits Lose Control in Cancer
Alexander Stein, Reinhard Jahn  Neuron 
Rethinking ALS: The FUS about TDP-43
RAS’s Cloak of Invincibility Slips at Last?
Gerry P. Crossan, Juan I. Garaycoechea, Ketan J. Patel  Cell Stem Cell 
FUS Zigzags Its Way to Cross Beta
Volume 21, Issue 2, Pages (August 2017)
The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients  Stephen J Elledge, Angelika Amon  Cancer.
Oh what a tangled web it weaves: BRCA1 and DNA decatenation
Volume 21, Issue 6, Pages (December 2017)
MDS Is a Stem Cell Disorder After All
DAISY: Picking Synthetic Lethals from Cancer Genomes
Volume 26, Issue 1, Pages 1-2 (July 2014)
Kidney Cancer: Now Available in a New Flavor
A Radical Role for p38 MAPK in Tumor Initiation
The AML Salad Bowl Cancer Cell
Cécile L. Maire, Keith L. Ligon  Cancer Cell 
Uncovering a Tumor Suppressor for Triple-Negative Breast Cancers
Cutaneous Cancer Stem Cells: β-Catenin Strikes Again
The Apoptosome at High Resolution
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Giulio Francia, Urban Emmenegger, Robert S. Kerbel  Cancer Cell 
Eukaryotic Transcription Activation: Right on Target
A New “Brew” of MALT1 Inhibitors
Focus on lymphangiogenesis in tumor metastasis
Volume 133, Issue 1, Pages (April 2008)
An Integrin-Linked Machinery of Cytoskeletal Regulation that Enables Experimental Tumor Initiation and Metastatic Colonization  Tsukasa Shibue, Mary W.
Volume 143, Issue 6, (December 2010)
Proteins in Plant Brassinosteroid Signaling
Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
Genome-Wide SNP Analysis in Cancer: Leukemia Shows the Way
MicroRNA-155 Function in B Cells
Marta Chesi, P. Leif Bergsagel  Cancer Cell 
A common pathway for genetic events leading to pheochromocytoma
It’s ALL in the Family: IKZF1 and Hereditary Leukemia
To Infinium, and Beyond! Cancer Cell
Volume 10, Issue 3, Pages (September 2006)
All Roads Lead to the Ribosome
The TRIP from ULF to ARF Cancer Cell
Glycogen Synthase Kinase-3 and Cancer: Good Cop, Bad Cop?
There's a Time and a Place for MYCN
Volume 17, Issue 2, Pages (February 2010)
Connecting with an Old Partner in a New Way
Ibrutinib Treatment of CLL: The Cancer Fights Back
Predicted pathogenic BRCA1 amino acid substitutions are confined to the evolutionarily conserved N- and C-terminal domains. Predicted pathogenic BRCA1.
Volume 12, Issue 6, Pages (December 2007)
Kidney Cancer: Now Available in a New Flavor
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
The AML Salad Bowl Cancer Cell
The Role of TET2 in Hematologic Neoplasms
Presentation transcript:

“Ring-Fencing” BRCA1 Tumor Suppressor Activity Ketan J. Patel, Gerry P. Crossan, Michael R.G. Hodskinson  Cancer Cell  Volume 20, Issue 6, Pages 693-695 (December 2011) DOI: 10.1016/j.ccr.2011.11.019 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Domain Organization and Structure of BRCA1 Top, Schematic representation of the BRCA1 polypeptide showing the N-terminal RING domain and the C-terminal BRCT domains. Point mutations discussed here are indicated. Bottom, The NMR structure of the BRCA1/BARD1 dimerized RING domains (Brzovic et al., 2001). The relevant key amino acids discussed here are highlighted. Cancer Cell 2011 20, 693-695DOI: (10.1016/j.ccr.2011.11.019) Copyright © 2011 Elsevier Inc. Terms and Conditions